After the CIA-induced rat model was established, treatment was initiated in the 4th week and continued for 12 times per week until the 16th week
In November 2025, after a pause of more than five years, the FDA approved a reformulated version of H2 blocker ranitidine that addresses the shelf-life deficiencies and impurities present in the previous versions
Taken together, the results of numerous small studies equivocally suggest that GLP-1 RA treatment in coronary artery disease patients would be beneficial, regardless of the presence of diabetes
Coordination between specialists may be beneficial, particularly if thyroid disease management is complex or if significant dose adjustments to levothyroxine are anticipated
Clinical trials for semaglutide show that digestive issues are common as the body adjusts to the dosage
During audits or inspections, companies must demonstrate that these consumables meet quality standards and do not present a contamination risk
